On May 17, The Bill Clinton Foundation announced that it had successfully negotiated price reductions of antiretroviral (ARV) drug regimens used to treat HIV/AIDS. The partnership of the Clinton Health Access Initiative (CHAI), UNITAID, and UK’s Department for International Development (DFID) has worked together in the past to successfully reduce prices. Since 2008 the organizations have yielded prescription savings of over $600 million worldwide. The latest price reductions were offered by eight Indian pharmaceutical companies that will allow modern ARVs to be sold at lower prices in developing nations...
No comments:
Post a Comment